“…MAPs make up a class of cytoskeletal proteins essential for the functions of microtubules and are generally believed to serve as microtubule‐connecting links to organelles, vesicles, and other cytoskeletal elements (Shepherd, 1994). MAP2 has also been used as a sensitive marker for brain damage in diverse disease models, including seizures (Ballough et al, 1995), ischemia and hypoxia (Kitagawa et al, 1989; Zhang et al, 1999; Kitano et al, 2004; Yushmanov et al, 2006; Pastori et al, 2007), and contusive brain injuries (Saatman et al, 2006). However, MAP2 was initially established as a marker that disappeared from the damaged neurons, which was detected immunohistochemically and was believed to have very limited use as a clinical diagnostic marker.…”